Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 4703608, 7 pages
http://dx.doi.org/10.1155/2016/4703608
Case Report

TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature

1Department of Medicine, Rhode Island Hospital and Warren Alpert School of Medicine, Brown University, Providence, RI, USA
2Department of Hematology and Oncology, Rhode Island Hospital, Providence, RI, USA
3Department of Pathology, Rhode Island Hospital, Providence, RI, USA

Received 15 July 2016; Accepted 25 August 2016

Academic Editor: Simon Davidson

Copyright © 2016 Malorie Simons et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kawabata, K. Takai, M. Kojima et al., “Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012),” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 57–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Fajgenbaum, F. van Rhee, and C. S. Nabel, “HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy,” Blood, vol. 123, no. 19, pp. 2924–2933, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-H. Chen, H.-C. Liu, T.-T. Hung, and T.-P. Liu, “Possible roles of Epstein-Barr virus in Castleman disease,” Journal of Cardiothoracic Surgery, vol. 4, article no. 31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Barozzi, M. Luppi, L. Masini et al., “Lymphotropic herpes virus (EBV, HHV-63 HHV-8) DNA sequences in HIV negative Castleman's disease,” Journal of Clinical Pathology—Clinical Molecular Pathology, vol. 49, no. 4, pp. M232–M235, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Masaki, H. Kawabata, K. Takai et al., “Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version,” International Journal of Hematology, vol. 103, no. 6, pp. 686–692, 2016. View at Google Scholar
  6. H. Wakiguchi, H. Hisakawa, H. Kubota, and T. Kurashige, “Strong response of T cells in infants with dual infection by Epstein-Barr virus and cytomegalovirus,” Pediatrics International, vol. 41, no. 5, pp. 484–489, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Kubokawa, A. Yachie, A. Hayakawa et al., “The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease,” BMC Pediatrics, vol. 14, no. 1, article 139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Inoue, M. Ankou, J. Hua, Y. Iwaki, and M. Hagihara, “Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report,” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 95–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kawabata, S.-I. Kotani, Y. Matsumura et al., “Successful treatment of a patient with multicentric castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody,” Internal Medicine, vol. 52, no. 13, pp. 1503–1507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ozawa, S. Kosugi, M. Kito et al., “Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease,” Rinshō Ketsueki, vol. 55, no. 3, pp. 350–355, 2014. View at Google Scholar · View at Scopus
  11. N. Iwaki, Y. Sato, K. Takata et al., “Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy,” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 87–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Masaki, A. Nakajima, H. Iwao et al., “Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 79–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Takai, K. Nikkuni, A. Momoi, K. Nagai, N. Igarashi, and T. Saeki, “Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases,” Journal of Clinical and Experimental Hematopathology, vol. 53, no. 1, pp. 63–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. E. El-Osta and R. Kurzrock, “Castleman's disease: from basic mechanisms to molecular therapeutics,” Oncologist, vol. 16, no. 4, pp. 497–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. Koduri, M. Parvez, S. Kaza, P. Pappu, and S. Anuradha, “Castleman-Kojima disease in a South Asian adolescent,” Journal of Clinical and Experimental Hematopathology, vol. 54, no. 2, pp. 163–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Iwaki, D. C. Fajgenbaum, C. S. Nabel et al., “Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease,” American Journal of Hematology, vol. 91, no. 2, pp. 220–226, 2016. View at Publisher · View at Google Scholar
  17. K. Takai, K. Nikkuni, H. Shibuya, and H. Hashidate, “Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly,” Rinsho Ketsueki, vol. 51, no. 5, pp. 320–325, 2010 (Japanese). View at Google Scholar
  18. L. A. Abdo, C. P. Morin, R. P. Collarino, J. P. Cabane, and M. A. Gatfosse, “First European case of TAFRO syndrome associated with Sjogren disease,” American Journal of Internal Medicine, vol. 2, no. 6, pp. 102–105, 2014. View at Publisher · View at Google Scholar